Original Research
Published on 23 Jun 2023
Interleukin 17 in early invasive breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1171254
- 3,546 views
- 7 citations
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
830 articles
Systematic Review
Published on 23 Jun 2023
Perioperative intravenous lidocaine for postoperative pain in patients undergoing breast surgery: a meta-analysis with trial sequential analysis of randomized controlled trials
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1101582
- 3,885 views
- 5 citations
Original Research
Published on 23 Jun 2023
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1191943
- 3,954 views
- 4 citations
Original Research
Published on 22 Jun 2023
An integrated radiomics nomogram based on conventional ultrasound improves discriminability between fibroadenoma and pure mucinous carcinoma in breast
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1170729
- 2,869 views
- 2 citations
Original Research
Published on 22 Jun 2023
Quantitative analysis of serum cell-free DNA as a predictive and prognostic marker in breast cancer patients
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1171412
- 5,103 views
- 4 citations
Systematic Review
Published on 21 Jun 2023
The accuracy of ultrasound-guided fine-needle aspiration and core needle biopsy in diagnosing axillary lymph nodes in women with breast cancer: a systematic review and meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1166035
- 4,737 views
- 9 citations
Original Research
Published on 20 Jun 2023
Tumor-infiltrating lymphocytes provides recent survival information for early-stage HER2-low-positive breast cancer: a large cohort retrospective study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1148228
- 2,488 views
- 3 citations
Original Research
Published on 19 Jun 2023
Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1136380
- 4,008 views
- 7 citations
Original Research
Published on 16 Jun 2023
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1152458
- 4,861 views
- 8 citations
Review
Published on 16 Jun 2023
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1155254
- 6,326 views
- 18 citations
Case Report
Published on 16 Jun 2023
Revitalizing quality of life: a case report on the beneficial impact of comprehensive rehabilitation therapy in treating upper-limb lymphedema following breast cancer surgery
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1046003
- 3,570 views
- 1 citation
Systematic Review
Published on 16 Jun 2023
Clinical diagnostic biomarker “circulating tumor cells” in breast cancer - a meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1137519
- 3,464 views
- 11 citations
Original Research
Published on 16 Jun 2023
Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1076469
- 1,832 views
- 4 citations
Original Research
Published on 16 Jun 2023
Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1179025
- 3,586 views
- 7 citations
Original Research
Published on 16 Jun 2023
Real-world data of pyrotinib-based therapy for patients with brain metastases of HER2-positive advanced breast cancer: a single-center retrospective analysis and molecular portraits
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1105474
- 3,315 views
- 2 citations
Original Research
Published on 15 Jun 2023
Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1175000
- 2,386 views